Should You Invest in the iShares Biotechnology ETF (IBB)?

1 day ago · Launched on 02/05/2001, the iShares Biotechnology ETF (IBB) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - …

CouponFollow Extension

88%
OFF

Should You Invest In The IShares Biotechnology ETF (IBB)? - MSN

3 weeks from now

Year-to-date, the iShares Biotechnology ETF return is roughly 4.88% so far, and was up about 3.47% over the last 12 months (as of 02/03/2025). IBB has traded between $124.64 and …

msn.com

88%
OFF

Should You Invest In The IShares Biotechnology ETF (IBB)?

3 weeks from now

1 day ago · Year-to-date, the iShares Biotechnology ETF return is roughly 4.88% so far, and was up about 3.47% over the last 12 months (as of 02/03/2025). IBB has traded between $124.64 …

zacks.com

14%
OFF

Should You Invest In The IShares Biotechnology ETF (IBB)?

3 weeks from now

Jul 19, 2023 · Year-to-date, the iShares Biotechnology ETF has lost about -1.14% so far, and is up roughly 7.91% over the last 12 months (as of 07/19/2023). IBB has traded between …

yahoo.com

11%
OFF

Should You Invest In The IShares Biotechnology ETF (IBB)?

3 weeks from now

Jul 31, 2024 · IBB has traded between $112.41 and $148.26 during this last 52-week period. The ETF has a beta of 0.74 and standard deviation of 22.11% for the trailing three-year period, …

zacks.com

56%
OFF

Should You Invest In The SPDR S&P Biotech ETF (XBI)?

3 weeks from now

1 day ago · First Trust NYSE Arca Biotechnology ETF has $1.21 billion in assets, iShares Biotechnology ETF has $6.52 billion. FBT has an expense ratio of 0.56% and IBB charges …

zacks.com

25%
OFF

Should You Invest In The IShares U.S. Industrials ETF (IYJ)?

3 weeks from now

1 day ago · Performance and Risk Year-to-date, the iShares U.S. Industrials ETF has gained about 5.25% so far, and was up about 24.16% over the last 12 months (as of 02/03/2025).

zacks.com

FAQs about Should You Invest in the iShares Biotechnology ETF (IBB)? Coupon?

What is the iShares biotechnology ETF (Ibb)?

Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the iShares Biotechnology ETF (IBB) is a passively managed exchange traded fund launched on 02/05/2001. ...

Is Ibb a good ETF for health care investors?

Because of this, IBB is a great option for investors seeking exposure to the Health Care ETFs segment of the market. There are other additional ETFs in the space that investors could consider as well. ...

Should you buy iShares biotechnology ETF?

With about 276 holdings, it effectively diversifies company-specific risk. IShares Biotechnology ETF holds a Zacks ETF Rank of 2 (Buy), which is based on expected asset class return, expense ratio, and momentum, among other factors. ...

Is Ibb (Ibb) a good stock to buy?

IBB has traded between $112.41 and $148.26 during this last 52-week period. The ETF has a beta of 0.74 and standard deviation of 22.11% for the trailing three-year period, making it a high risk choice in the space. With about 221 holdings, it effectively diversifies company-specific risk. ...

Which biotech ETF has the most assets?

First Trust NYSE Arca Biotechnology ETF has $1.21 billion in assets, SPDR S&P Biotech ETF has $6.34 billion. FBT has an expense ratio of 0.56% and XBI charges 0.35%. Bottom Line ...

What does Ibb do?

IBB seeks to match the performance of the Nasdaq Biotechnology Index before fees and expenses. The ICE Biotechnology Index contains securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceuticals. ...